PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: patents
First 'Real' European Patent Imminent
It’s exciting times for patents in Europe. Not everyone’s excitement is pleasurable, but there’s certainly plenty going on, writes Reflector, Pharm Exec’s EU correspondent.
Much of the excitement is linked to the imminent advent of Europe’s first real European patent. After decades of failed attempts, by the beginning of 2014 the European Union will finally have [...]
Posted in Europe, Guest Blog, IP Also tagged EU, Europe, European Generics Association, IPR, unitary patent 1 Comment
Three Questions to Ask About Your Life Sciences Patents
By Marian T. Flattery and Michael J. Flibbert
The decisions you make today about patents – what, when and where to file – could have implications tantamount to billions of dollars in R&D investment and sales over the next two decades. Given the increasing importance of lifecycle management in the context of increasing generic usage [...]
Posted in IP, Legal, R&D Also tagged America Invents Act, US Patent and Trademark Office Leave a comment
Supreme Court: Prometheus Decision a Harbinger for Myriad?
In judging the Prometheus patents invalid, the Supreme Court may have shown its hand on the upcoming Myriad Genetics case.
In a unanimous decision on Tuesday, the Supreme Court stripped two Prometheus patents on the grounds that the company didn’t go far enough beyond merely identifying a natural law. Natural laws – a product [...]
Posted in Biotech, Gene therapy, IP, Legal, Regulatory, Strategy Also tagged United States Supreme Court Leave a comment
Medicines Patent Pool: Industry's Toe Still in the Water